BELLEVUE, Wash., Oct. 1, 2019 /PRNewswire/ — Healthcare Management Administrators (HMA) is excited to announce the launch of a new quality comparison transparency technology.
HMA is the first Healthcare company on the west coast and the first Third-Party-Administrator in the United States to launch Doctor Quality™, the latest innovation from HMA’s longtime partner Healthcare Bluebook™. Doctor Quality™ analyzes five patient outcome-based metrics to rank doctors by specialty and procedure. HMA’s Chief Client Officer, Lindsay Harris, commented that “Doctor Quality™ empowers healthcare consumers with the power of big data to make better-informed choices. Many people ask friends for referrals to a good surgeon. That’s one approach. Wouldn’t you also like to know you’ve chosen the surgeon with the best patient survival, safety, quality, and the lowest complications and re-hospitalization rates? I know I would. That’s why we’ve chosen to be the first-to-market to offer our self-insured clients this powerful new technology.”
Founded in Bellevue, WA in 1986, HMA is now one of the nation’s largest third-party healthcare benefits administrators. HMA’s growth is a result of its proven expertise in looking out for the health of its clients and their employees. HMA- Proving What’s Possible In Healthcare®.
Healthcare Management Administrators, Inc. www.accesshma.com | www.hmaconnect.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/pacific-northwest-healthcare-insurance-innovator-hma-is-first-to-market-with-new-doctor-quality-comparison-technology-300928307.html
SOURCE Healthcare Management Administrators
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…